The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feng, C. G.
Right arrow Articles by Sher, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, C. G.
Right arrow Articles by Sher, A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Tuberculosis
The Journal of Immunology, 2003, 171: 4758-4764.
Copyright © 2003 by The American Association of Immunologists

Mice Lacking Myeloid Differentiation Factor 88 Display Profound Defects in Host Resistance and Immune Responses to Mycobacterium avium Infection Not Exhibited by Toll-Like Receptor 2 (TLR2)- and TLR4-Deficient Animals

Carl G. Feng1,*, Charles A. Scanga*, Carmen M. Collazo-Custodio2,*, Allen W. Cheever{dagger}, Sara Hieny*, Patricia Caspar* and Alan Sher*

* Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and {dagger} Biomedical Research Institute, Rockville, MD 20852


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
To assess the role of Toll-like receptor (TLR) signaling in host resistance to Mycobacterium avium infection, mice deficient in the TLR adaptor molecule myeloid differentiation factor 88 (MyD88), as well as TLR2-/- and TLR4-/- animals, were infected with a virulent strain of M. avium, and bacterial burdens and immune responses were compared with those in wild-type (WT) animals. MyD88-/- mice failed to control acute and chronic M. avium growth and succumbed 9–14 wk postinfection. Infected TLR2-/- mice also showed increased susceptibility, but displayed longer survival and lower bacterial burdens than MyD88-/- animals, while TLR4-/- mice were indistinguishable from their WT counterparts. Histopathological examination of MyD88-/- mice revealed massive destruction of lung tissue not present in WT, TLR2-/-, or TLR4-/- mice. In addition, MyD88-/- and TLR2-/-, but not TLR4-/-, mice displayed marked reductions in hepatic neutrophil infiltration during the first 2 h of infection. Although both MyD88-/- and TLR2-/- macrophages showed profound defects in IL-6, TNF, and IL-12p40 responses to M. avium stimulation in vitro, in vivo TNF and IL-12p40 mRNA induction was impaired only in infected MyD88-/- mice. Similarly, MyD88-/- mice displayed a profound defect in IFN-{gamma} response that was not evident in TLR2-/- or TLR4-/- mice or in animals deficient in IL-18. These findings indicate that resistance to mycobacterial infection is regulated by multiple MyD88-dependent signals in addition to those previously attributed to TLR2 or TLR4, and that these undefined elements play a major role in determining bacterial induced proinflammatory as well as IFN-{gamma} responses.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Toll-like receptors (TLR)3 play a role in innate defense by recognizing distinct molecular patterns associated with microbial pathogens (1, 2, 3). For example, TLR2 is involved in the response to products of Gram-positive bacteria and yeasts (2, 4, 5, 6), while TLR4 is required for the recognition of endotoxin of Gram-negative bacteria (4, 7, 8). Stimulation of TLR by microbial products activates NF-{kappa}B and other signaling pathways to produce inflammatory cytokines (2, 9). All TLR share homology with the other members of the IL-1R/TLR superfamily, such as the receptors for IL-1 and IL-18 that also trigger NF-{kappa}B function.

Signal transduction by all of the known TLR, as well as IL-1R/IL-18R, requires an adapter molecule, myeloid differentiation factor 88 (MyD88) (10, 11, 12). For this reason, MyD88-/- mice have been used as a tool for studying the role of TLR in innate and adaptive immunity. MyD88-/- animals fail to generate both proinflammatory and Th1 responses when stimulated with TLR ligands (11, 12, 13). These animals are highly susceptible to infection with a wide variety of different pathogens, including Staphylococcus aureus (14), Listeria monocytogenes (15, 16), and Toxoplasma gondii (17), indicating a critical role for MyD88 in host resistance to microbial infection.

Mycobacterium avium is the causative agent of one of the most common opportunistic infections occuring in immunocompromised individuals (18, 19, 20). Similar to Mycobacterium tuberculosis, M. avium stimulates a predominantly cell-mediated immune response, characterized by the production of IFN-{gamma} and other proinflammatory cytokines. This response is thought to play a critical role in host resistance by containing the intracellular growth of the bacteria within macrophages (21, 22). Studies in IFN-{gamma} and IL-12 knockout (KO) mice have confirmed an important function for these cytokines in the control of M. avium infection in vivo (23, 24).

To assess the role of the TLR/IL-1R superfamily in induction of host resistance to M. avium, we studied the course of infection in animals deficient in MyD88. Because both TLR2 and TLR4 have been previously implicated in the immune control of M. tuberculosis (25, 26), we also examined the susceptibility of mice deficient in these specific TLR to M. avium challenge. The MyD88-/- animals display dramatically increased susceptibility to M. avium infection, a phenotype that correlates with profound defects in neutrophil recruitment, proinflammatory cytokine responses, and CD4+ T cell-dependent IFN-{gamma} production. Although not as severe, TLR2-deficient mice also showed impaired host resistance and neutrophil responses to the bacteria. In contrast, infected TLR4 KO animals were indistinguishable from WT controls. These findings suggest that in addition to TLR2, host control of M. avium infection involves other, as yet to be defined, MyD88-dependent members of the IL-1/TLR superfamily that are specifically required for the generation of the Th1 cytokine response to this pathogen.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

Breeding pairs of MyD88-/-, TLR2-/-, and TLR4-/- mice, obtained from Dr. S. Akira (Osaka University, Osaka, Japan) via Dr. D. Golenbock (University of Massachusetts Medical School, Worcester, MA), were used after four to five generations of backcrossing to the C57BL/6 mice. IL-18-/- mice (27) (on C57BL/6 background) were kindly provided by Dr. R. Caspi (National Eye Institute, National Institutes of Health,Bethesda, MD). Mice deficient in IFN-{gamma} (IFN-{gamma}-/-, on B6 background) or IL-1R{beta} (IL-1RI-/-, on B6129 background) were purchased from The Jackson Laboratory (Bar Harbor, ME). Wild-type (WT) B6/129S1 and C57BL/6 mice were obtained from Taconic (Taconic Farms, Germantown, NY). All mice were maintained at American Association of Laboratory Animal Care-accredited animal facility at the National Institute of Allergy and Infectious Diseases, National Institutes of Health. Mice of both sexes between 8 and 12 wk old were used in all experiments.

Because natural resistance-associated macrophage protein gene (Nramp)1 has been shown to influence the resistance of mice to M. avium infection (28, 29), we determined the Nramp1 genotype of the partially backcrossed MyD88- and TLR-deficient mice by a published method (30). We found that all three KO lines displayed the Nramp1 susceptibility allele (data not shown), which is expressed by the C57BL/6 parental strain. For this reason, host resistance and immune responses of MyD88 and TLR KO mice to M. avium infection were compared with those of C57BL/6 animals, although B6129 mice were also included as controls.

M. avium infection and soluble bacterial Ags

Mice were infected i.v. with 1 x 106 CFU of M. avium (strain 2-151-SmT). Bacterial loads in liver and lungs of infected mice were determined at various time points following infection, as previously described (31). Soluble M. avium Ags (MAVAg) were also prepared, as described (31).

Tissue cultures and cytokine assays

Single-cell suspensions were prepared from spleens of naive and infected mice. To isolate splenic CD4+ T cells, splenocytes were first passed through T cell enrichment columns (R&D Systems, Minneapolis, MN). The enriched T cell populations were then labeled with mAb specific for CD4 and positively selected using magnetic cell sorting (Miltenyi Biotec GmbH, Auburn, CA). Total splenocytes (4 x 106/ml) were stimulated with medium or MAVAg (20 µg/ml) for 72 h in RPMI 1640 medium supplemented with 10% heat-inactivated FCS, 100 U/ml penicillin, 100 µg/ml streptomycin, 2 µM glutamine, 10 mM HEPES, and 50 µM 2-ME. IFN-{gamma} levels in culture supernatants were determined by ELISA, as previously described (31). When purified CD4+ T cells (1 x 106/ml) were used, irradiated splenocytes (4 x 106/ml) from naive animals were added as a source of APC.

Measurement of in vitro macrophage function

Bone marrow cells were cultured for 7 days in complete RPMI supplemented with 20% L929 cell culture supernatant. Adherent macrophages were then plated in triplicates in 48-well plates at 105 cells/well and stimulated with 100 U/ml murine IFN-{gamma} in antibiotic-free medium for 16 h. To assess macrophage responses, the cultures were stimulated with a purified TLR2 ligand, Borrelia burgdorferi outer surface protein (OSP)-A (5 µg/ml), or a TLR4 ligand, LPS (100 ng/ml, Escherichia coli serotype O55:B5; Sigma-Aldrich, St. Louis, MO). Alternatively, macrophages were infected with live M. avium (multiplicity of infection, 10:1) for 4 h; the adherent cells were washed twice; and fresh complete RPMI was added. Culture supernatants were collected 72 h after stimulation or infection, and TNF-{alpha}, IL-6, and IL-12 p40 levels were assessed by ELISA using commercial kits (R&D Systems) or previously published assays (31). Following removal of supernatants, M. avium-infected macrophages were lysed using 1% saponin. The cell lysates were cultured on 7H11 agar to determine bacterial CFU.

Real-time RT-PCR measurement of cytokine mRNA

Liver tissue was homogenized in 1 ml of TRIzol (Invitrogen, San Diego, CA). Total RNA was extracted according to the manufacturer’s directions with an additional chloroform extraction. One microgram of total RNA was reverse transcribed using Super Script II RNase H- reverse transcriptase (Invitrogen). The cDNA was then subjected to real-time RT-PCR using SYBR Green (Applied Biosystems, Foster City, CA) on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems). The following primer pairs were used: hypoxanthine phosphoribosyltransferase, GTTGGATACAGGCCAGACTTTGTTG (F) and GATTCAACTTGCGCTCATCTTAGGC (R); IFN-{gamma}, GGCCATCAGCAACAACATAAGC (F) and AATCTGAGTTCAGTCAGCCGCTT (R); TNF-{alpha}, TTCTGTCTACTGAACTTCGGGGTG (F) and GGAAGACTCCTCCCAGGTATATGG (R); IL-12p40, CTCACATCTGCTGCTCCACAAG (F) and AATTTGGTGCTTCACACTTCAGG (R). Each sample was normalized to hypoxanthine phosphoribosyltransferase, and gene expression relative to the level in uninfected controls was calculated.

Analysis of neutrophil recruitment

Total hepatic leukocytes were isolated by the method of Bertolino et al. (32). Briefly, livers were perfused with PBS to remove blood leukocytes. A single-cell suspension was prepared by sieving liver lobes through a 100-µm-pore-size mesh. Liver leukocytes were enriched by Percoll gradient centrifugation and stained with mAb specific for Gr-1, CD11b, and I/A (BD Biosciences, San Diego, CA). The percentage of granulocytes (Gr-1+CD11b+I/A-) among hepatic leukocytes was determined by flow cytometry using a FACSCalibur (BD Immunocytometry System, San Jose, CA). Data were collected and analyzed with the CellQuest program.

Histopathology

Tissue sections from livers and lungs were fixed with Formalin, sectioned, and stained with H&E. The Ziehl-Neelsen method was used to stain acid-fast mycobacteria in tissue sections.

Statistics

ANOVA was used to analyze the significance of differences in means between multiple experimental groups. The multicomparison significance level for the one-way ANOVA was 0.05. If significance was detected by one-way analysis, pair-wise differences were evaluated using Fisher’s protected least significant difference ANOVA post hoc test. Statistical significance was defined as p < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
MyD88-/- mice fail to control M. avium replication and succumb to the infection

To investigate the role of TLR/MyD88 signaling in host defense against mycobacterial infection in vivo, MyD88-/-, TLR2-/-, TLR4-/-, and WT control C57BL/6 and B6/129 animals were infected i.v. with M. avium (106 CFU). Survival of animals and hepatic and pulmonary bacterial loads was compared at various time points thereafter. All MyD88-/- mice succumbed between 9 and 14 wk postinfection (p.i.), whereas the WT B6 or B6129 (data not shown), TLR2-/-, and TLR4-/- animals showed 100% survival during the same period. By 16–22 wk, however, TLR2 mice also succumbed to the infection. In contrast, the majority of TLR4 animals survived for the 25-wk course of the experiment (Fig. 1).



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 1. Infected MyD88-/- mice display increased mortality relative to both TLR-deficient and WT animals. Survival of MyD88-/-, TLR2-/-, TLR4-/-, and WT C57BL/6 mice (n = 10–15/group) was monitored following i.v. M. avium infection. Data are pooled results from two separate experiments that gave nearly identical results.

 
The accelerated mortality of infected MyD88-/- mice was associated with uncontrolled mycobacterial proliferation in the liver and lungs. When bacterial burdens were assayed in liver, MyD88-/- mice showed 1–1.5 log10 increases in CFU compared with Nramp1 coisogenic C57BL/6 WT controls at 2 and 6 wk postinfection (Fig. 2). An even larger increase in bacterial counts was evident in the lungs of the same MyD88 KO animals at wk 6 following mycobacterial exposure.



View larger version (39K):
[in this window]
[in a new window]
 
FIGURE 2. MyD88-/- mice show significantly impaired control of M. avium growth. Hepatic and pulmonary bacterial burdens (CFU) in WT and KO mice were compared at wk 2 (gray bar) and 6 (filled bar) following i.v. infection with M. avium. The means (± SD) of three to four mice per time point are shown. The significance of the differences in CFU between WT and KO strains was compared by ANOVA (*, p < 0.05). The experiment shown is representative of two performed.

 
Because both TLR2 and TLR4 have been implicated in host resistance to mycobacterial infection (25, 26), we also evaluated bacterial burdens in mice deficient for these two MyD88-associated TLR. Hepatic bacterial burdens were significantly elevated in TLR2-/- relative to WT controls at both 2 and 6 wk, while TLR4-/- mice showed no significant increases. A similar elevation in CFU was observed in the lungs of TLR2, but not TLR4, KO mice at wk 6 p.i. This difference in host resistance between TLR2-/- and TLR4-/- animals was maintained into the chronic phase of infection. At 10 wk p.i., bacterial CFU in TLR2-/- mice (log10 8.8 ± 0.5 and 6.9 ± 0.2 in liver and lung, respectively) were significantly higher (p < 0.05) than those measured in either WT (log10 7.8 ± 0.2 and 5.8 ± 0.1) or TLR4-/- (log10 7.9 ± 0.1 and 5.6 ± 0.1) animals. Accurate bacterial burdens could not be determined on chronically infected MyD88-/- mice because of their mortality during this period. Nevertheless, at each of the earlier time points examined, the MyD88-/- mice showed higher bacterial loads than TLR2-/- animals (Fig. 2). The latter difference was particularly striking when CFU were measured in lung. Interestingly, bacterial burdens in the lungs of MyD88 KO mice exceeded even those of IFN-{gamma} KO mice, although no difference was observed in the liver.

In addition to TLR signaling, MyD88 also controls IL-1R- and IL-18R-dependent cellular activation (11). To examine the possible role of these cytokine receptors in the effects of MyD88 deficiency on M. avium infection, bacterial burdens were also examined in IL-18-/- mice as well as mice deficient in IL-1R. No significant differences in CFU were evident in lung or liver of IL-1R-/- or IL-18-/- mice in comparison with their background-matched controls.

MyD88-/- mice display impaired granuloma function and exacerbated pulmonary pathology

Because the granulomatous response plays a critical role in controlling mycobacterial dissemination, we next examined whether granuloma formation and bacterial replication within these tissue lesions differ between infected WT and KO mice. Hepatic granulomas of MyD88 and TLR KO mice did not show any apparent changes in leukocyte composition at wk 2 and 6 p.i. (data not shown). The size of hepatic granulomas appeared to be similar in all mouse strains (Fig. 3, A–D), and this was confirmed by direct measurement of mean lesion diameters (WT = 57.1 ± 5.9 µm, MyD88-/- = 64.6 ± 5.2 µm, TLR4-/- = 61.6 ± 5.2 µm, TLR2-/- = 69.0 ± 6.7 µm, n = 4). No tissue necrosis was evident in the hepatic tissue sections of any of the mouse strains examined. Bacilli were largely confined within granulomas in both WT and MyD88-/- animals. However, in contrast to the hepatic granulomas in WT mice (Fig. 3E), in which only a few bacteria were detected by acid-fast staining, those in MyD88-/- mice contained large numbers of bacilli (Fig. 3F).



View larger version (207K):
[in this window]
[in a new window]
 
FIGURE 3. MyD88-/- mice show impaired bacterial clearance within hepatic granulomas and exacerbated pulmonary pathology. Formalin-fixed, paraffin-embedded hepatic (A–F) and pulmonary (G–L) tissue sections from 6-wk infected mice were stained with H&E. Acid-fast bacilli in hepatic granulomas were identified with the Ziehl-Neelsen method (E and F). Positively stained M. avium bacilli in hepatic sections are indicated by arrows. The representative sections shown are from infected WT (A, E, G, and K), MyD88-/- (B, F, H, and L), TLR2-/- (C and I), and TLR4-/- (D and J) mice. Magnification shown is x200, except for K and L, which are x600.

 
Histological examination of lungs in infected MyD88-/- (Fig. 3, H and L) mice revealed dramatic pathological changes not evident in WT (Fig. 3, G and K), TLR2-/- (Fig. 3I), TLR4-/- (Fig. 3J), or IFN-{gamma}-/- or IL-18-/- mice (data not shown). Small granulomas that contained approximately equal numbers of macrophages and lymphocytes developed in the lungs of WT, TLR2-/-, and TLR4-/- mice. In contrast, pulmonary granulomas were much larger in MyD88-/- animals and formed destructive lesions composed mainly of necrotic macrophages and lymphocytes that occupied ~40% of the lung area (Fig. 3, H and L).

Impaired neutrophil recruitment in M. avium-infected MyD88-/- and TLR2-/- mice

It has been shown previously that following i.v. inoculation, bacteria are taken up by Kupffer cells in the liver, where they provoke a rapid neutrophil response that is thought to play a role in reducing early pathogen loads (33, 34). For this reason, we asked whether a defect in early neutrophil recruitment might underlie the increased susceptibility of either MyD88- or TLR2-deficient mice to M. avium infection. To perform this analysis, livers were collected from mice 2 h following i.v. bacterial inoculation (5 x 106 CFU per animal), and hepatic Gr-1+CD11b+ neutrophils were quantitated by flow cytometry. In agreement with published data on other bacterial infection models (33, 34), M. avium infection led to a significant increase in the percentage as well as absolute numbers of Gr-1+CD11b+ (I/A-, data not shown) cells in the livers of WT and TLR4-/- mice compared with uninfected animals (Fig. 4, A and B, and data not shown). In contrast, infected MyD88-/- and TLR2-/- mice failed to show a major increase in either the number or the percentage of neutrophils when examined at the same time point.



View larger version (32K):
[in this window]
[in a new window]
 
FIGURE 4. MyD88-/- and TLR2-/- mice display impaired hepatic neutrophil influx during acute M. avium infection. Leukocytes isolated from livers of WT, MyD88-/-, TLR2-/-, and TLR4-/- animals at 2 h p.i.; stained with anti-GR-1, CD11b, and I/A mAb; and analyzed by flow cytometry. The percentages (A) and absolute numbers (B) of GR-1+CD11b+ leukocytes are shown. The mean (±SD) of three individual mice is shown. The experiment shown is representative of two performed.

 
MyD88 is required for the proinflammatory cytokine response to M. avium infection

MyD88 regulates the induction of proinflammatory cytokines by microbial products from macrophages and dendritic cells. To assess whether the enhanced susceptibility of MyD88-/- mice to M. avium infection is associated with an impaired cytokine production, we compared IL-6, TNF, and IL-12p40 responses of bone marrow-derived macrophage from KO and WT animals with M. avium infection in vitro. Upon stimulation with TLR agonists (OSP-A and LPS for TLR2 and TLR4, respectively) or infection with live M. avium, macrophages from WT mice produced high levels of IL-6, TNF, and IL-12p40 (Fig. 5A). In contrast, MyD88-/- macrophages failed to produce the same cytokines in response to either M. avium infection or TLR2 or TLR4 ligand stimulation. As expected, TLR2-/- macrophages responded to stimulation with LPS, but not OSP-A, and produced reduced levels of the three proinflammatory cytokines when exposed to M. avium. In contrast, M. avium-stimulated TLR4-/- macrophage displayed unimpaired inflammatory cytokine responses comparable to WT cells, confirming that recognition of M. avium products in vitro is mediated largely by TLR2, as previously reported (6, 35). In the same experiments, we also compared levels of intracellular infection of M. avium-exposed, IFN-{gamma}-primed macrophages at 72 h p.i. by measuring CFU in cell lysates. We found no major differences in bacterial counts in the WT, MyD88-/-, TLR2-/-, and TLR4-/- macrophage cultures during this period (data not shown). Consistent with the in vitro findings concerning proinflammatory cytokine production, in vivo TNF and IL-12p40 mRNA levels in livers were significantly reduced in 2-wk infected MyD88-/- as measured by RT-PCR. However, the levels of the same cytokines in the livers of infected TLR2-/- mice were comparable to those in TLR4-/- and WT animals (Fig. 5B).



View larger version (26K):
[in this window]
[in a new window]
 
FIGURE 5. MyD88 is essential for proinflammatory cytokine responses to M. avium infection. A, MyD88-/- and TLR2-/- macrophages show diminished production of IL-6, TNF, and IL-12p40 in response to M. avium infection in vitro. Bone marrow-derived macrophages from WT and KO mice were stimulated with OSP-A, LPS, or live M. avium. Secreted IL-6, TNF, and IL-12p40 were determined 72 h later by ELISA. The data shown are the means (±SD) of triplicate cultures. B, TNF and IL-12p40 mRNA expression is impaired in the livers of 2-wk infected MyD88-/-, but not TLR2-/- or TLR4-/-, mice. Cytokine mRNA levels were determined by real-time PCR and expressed as fold increase compared with the baseline levels of uninfected animals. The mean (±SD) of three to four individual mice is shown. Data shown are representative of two separate experiments performed.

 
M. avium-infected MyD88-/- mice display impaired IFN-{gamma} responses

It is known that mycobacterial infection stimulates a strong Th1 response associated with production of IFN-{gamma}. This adaptive immune response is essential for containing bacterial growth within granulomas in vivo. To investigate whether MyD88-/- mice generate a normal Th1 response following M. avium infection, splenic CD4+ T cells purified from 2-wk infected mice were stimulated with MAVAg in the presence of naive splenocytes from WT animals and secreted IFN-{gamma} measured 72 h later. As shown in Fig. 6A, production of IFN-{gamma} by CD4+ T cells of MyD88-/- mice was impaired compared with WT as well as TLR2- and TLR4-deficient animals. The diminished IFN-{gamma} production in infected MyD88-/- mice was not due to the induction of a Th2 response in these animals because neither IL-4 nor IL-5 was detected in the same cultures (data not shown).



View larger version (15K):
[in this window]
[in a new window]
 
FIGURE 6. M. avium-induced IFN-{gamma} production is impaired in MyD88-/-, but not TLR2-/- or TLR4-/-, mice. A, Purified splenic CD4+ T cells from 2-wk infected WT, MyD88-/-, TLR2-/-, and TLR4-/- mice were restimulated with MAVAg for 72 h. IFN-{gamma} in the culture supernatants was then measured by ELISA. B, Expression levels of IFN-{gamma} mRNA in the livers of 2-wk infected animals were determined by real-time PCR and presented as fold increase compared with that in uninfected animals. The mean (±SD) from three to four individual mice is shown. C, Splenocytes isolated at weekly intervals from infected WT (B6129, open symbol) and MyD88-/- (filled symbol) mice were restimulated with MAVAg and secreted IFN-{gamma} measured 72 h later by ELISA. The mean (±SD) of data points from three to four individual mice is shown. The experiment shown in each panel is representative of two performed.

 
To confirm that the impairment in IFN-{gamma} production observed ex vivo also occurs in vivo, we measured mRNA levels for the cytokine in the livers of KO and WT mice (Fig. 6B). At 2 wk p.i., IFN-{gamma} mRNA levels in the infected MyD88-/- mice were ~30-fold lower relative to WT controls. In contrast, IFN-{gamma} mRNA levels in livers of infected TLR2- and TLR4-deficient animals were not significantly different from WT control levels.

Because it was possible that the defect in IFN-{gamma} production in 2-wk infected MyD88-/- merely reflects a delay in this cytokine response, we measured MAVAg-induced IFN-{gamma} synthesis by spleen cells over a 4-wk interval following infection. As shown in Fig. 6C, spleen cells from MyD88-/- mice showed severely impaired IFN-{gamma} production throughout the entire course of this experiment.

Because the impairment in M. avium-specific IFN-{gamma} production in MyD88 KO mice could also be a result of the absence of IL-18R signaling (36), we examined the possible contribution of IL-18 in IFN-{gamma} responses to M. avium infection. When purified CD4+ T cells from 2-wk infected mice were restimulated with MAVAg in vitro, CD4+ T cells from IL-18-/- and WT mice produced similar levels of IFN-{gamma} (WT vs IL-18-/- mice, 6.48 ± 0.1 and 7.81 ± 0.45 ng/ml, respectively). Similarly, mRNA levels of IFN-{gamma} in the livers of the IL-18-/- mice were comparable to those of WT animals (data not shown).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Although TLR signaling has been implicated in the host response to mycobacteria, most of the evidence has been obtained from in vitro studies in which both TLR2 and TLR4 have been shown to regulate cytokine as well as NF-{kappa}B activation following stimulation with either live bacteria or mycobacterial products (6, 35, 37, 38). In different reports, these two TLR family members have also been shown to have significant, but partial effects on control of M. tuberculosis infection in mice (25, 26). In the present study, we have compared host resistance and immune responses to M. avium in MyD88-/-, TLR2-/-, and TLR4-/- animals with the goal of assessing the relative contribution of these as well as additional TLR in mycobacterial immunity.

We observed that MyD88-/- mice are significantly more susceptible to M. avium infection than either of the two TLR-deficient strains. Moreover, in agreement with one recent study with M. tuberculosis (26), we found that TLR4-/- mice are indistinguishable from WT controls in both bacterial burden and immune responses. This finding is also consistent with previously published in vitro observations, indicating that M. avium stimulates human TLR2, but not TLR4 function (6, 35). The difference in bacterial load between MyD88-/- and TLR2-/- mice was most pronounced in the lung at 6 wk postinfection, at which time point massive necrotic lesions were evident throughout the lung that were not present in WT, TLR2-/-, TLR4-/-, IL-18-/-, or IFN-{gamma}-/- animals. Similar destructive lesions were observed in livers of M. avium-infected TNFRp55-/- mice by Ehlers et al. (39), raising the possibility that the pathology occurring in infected MyD88-/- mice may be a consequence of the impaired TNF production seen in the latter animals. Nevertheless, in contrast with the previous findings in TNFRp55-/- mice, we failed to observe significant tissue destruction in liver sections from M. avium-infected MyD88-/- animals. The latter finding suggests that MyD88-dependent effector mechanisms are of greater importance in the control of bacterial growth in the lung, as opposed to liver. This observation may relate to differences in effector cell populations in the lung as compared with other organs.

M. avium-infected MyD88-/- mice also showed greater defects in mycobacterium-induced immune responses than any of the other gene-deficient animals examined in this study, although some of these defects were shared with other deficient mouse strains. The most profound immune response impairments were seen in the proinflammatory and Th1-associated cytokine responses mounted by MyD88-/- animals. Thus, while bone marrow-derived macrophages from both MyD88-/- and TLR2-/- mice were defective in their production of IL-6, IL-12p40, and TNF in vitro, only MyD88-/- mice showed impaired IL-12p40 and TNF mRNA expression in vivo. Similarly, MyD88-/-, but not TLR2-/-, mice showed reduced IFN-{gamma} production by CD4+ T cells ex vivo or diminished IFN-{gamma} mRNA levels in liver in situ. Importantly, M. avium-infected IL-18-/- mice failed to show the same defects in IFN-{gamma} response, arguing that the observed impairment in M. avium-specific IFN-{gamma} production in MyD88 KO mice is not a result of the absence of IL-18R signaling.

Although infected MyD88-/- mice showed unique defects in cytokine production, they shared with TLR2-/- animals a major defect in early recruitment of neutrophils to the liver. Pathogens that transit through the blood during acute infection are subject to hepatic clearance mediated jointly by resident tissue macrophages, Kupffer cells, and neutrophils recruited to the liver in response to microbial stimulation (33, 34). In the case of M. avium (40, 41), M. tuberculosis (42), and BCG (43) infections, depletion of neutrophils results in an early increase in bacterial growth, suggesting an important role for these host cells in innate defense against mycobacteria. Nevertheless, the nature of the pattern recognition events responsible for the induction of neutrophil recruitment by bacteria is poorly understood. Our observation of defective influx of neutrophils into livers of acutely infected MyD88- and TLR2-deficient mice indicates that TLR signaling plays an important role in triggering this cellular event and is in agreement with similar observations made in a model of Listeria infection (15).

Although the observed defect in neutrophil recruitment in MyD88- and TLR2-deficient mice may result from impaired chemokine production, preliminary experiments failed to reveal significant differences in the expression of mRNAs for the neutrophil chemotactic chemokines, KC and macrophage-inflammatory protein-2, in livers of WT and KO animals at 2 and 6 h p.i. (data not shown). An alternative possibility is that the impaired neutrophil migration in infected MyD88-/- and TLR2-/- animals results from a defect in the response of the neutrophils themselves to mycobacterial stimulation. In this regard, the 19-kDa mycobacterial lipoprotein, a TLR2 ligand, has been shown to directly activate neutrophil functions (44). Nevertheless, it remains to be determined whether the response to this or other bacterial derived TLR2 ligands triggers neutrophil migration in vivo or whether the absence of early neutrophil accumulation is a contributing factor in the impaired control of M. avium infection in TLR2-/- and MyD88-/- animals.

An important conclusion of the current study is that while MyD88 is absolutely required, TLR2 is dispensable for the generation of some antimycobacterial effector mechanisms. This is particularly true for the responses measured in vivo or ex vivo (e.g., levels of IFN-{gamma}, IL-12p40, and TNF), in which infected TLR2-/- mice were indistinguishable from WT animals. Because TLR2-/- macrophages are nevertheless defective in their response to M. avium in vitro, one possibility is that the in vivo loss of immune function due to TLR2 deficiency is compensated efficiently by other MyD88-dependent signaling pathways, such as those triggered by IL-1 and IL-18. Moreover, tissue pathology resulting from mycobacterial infection may also contribute to MyD88-dependent cellular activation via a TLR4-dependent pathway, as demonstrated by recent studies showing that heat shock proteins (45, 46), hyaluronan (47), and fibronectins (48) released from damaged cells can trigger TLR4 signaling. Whether such MyD88-dependent functions become overexpressed in infected TLR2-/- mice, thereby compensating for the loss in TLR2 function, remains to be determined.

Alternatively, the marked susceptibility to M. avium infection of MyD88-/- relative to TLR2-/- mice may reflect the requirement for multiple TLR, including TLR2, in host resistance to mycobacterial infection. Such TLR may include TLR9, which is likely to be triggered by CpG oligonucleotides presented in mycobacterial DNA (49, 50, 51), or TLR4, which although not required in itself for control of M. avium infection in our experiments, may nevertheless play a synergistic role with TLR2 in generating the appropriate effector response. A final possibility is that the enhanced susceptibility of infected MyD88-/- mice is due to the involvement of as yet to be identified pathway(s) requiring the MyD88 adaptor molecule. Studies in mice with combined deficiency in multiple TLR should help in distinguishing between these alternative explanations of the relative contributions of MyD88 and TLR2 in host control of mycobacterial infection.

The findings presented in this work underscore the major role played by innate signaling mechanisms in host resistance to mycobacteria. Further delineation of these pathways may lead to important information concerning determinants of host susceptibility to mycobacterial diseases in humans as well as to improved strategies for antimycobacterial immunization.


    Acknowledgments
 
We are grateful to Drs. Damien Chaussaabel, Dragana Jankovic, Warwick Britton, and Karen Elkins for their helpful comments and suggestions during the course of this project.


    Footnotes
 
1 Address correspondence and reprint requests to Dr. Carl Feng, Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Room 6148, Building 50, 50 South Drive, Bethesda, MD 20892-8003. E-mail address: cfeng{at}niaid.nih.gov Back

2 Current address: Laboratory of Mycobacterial Diseases and Cellular Immunity, Division of Bacterial and Parasitic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852. Back

3 Abbreviations used in this paper: TLR, Toll-like receptor; KO, knockout; MAVAg, soluble M. avium Ag; MyD88, myeloid differentiation factor 88; Nramp, natural resistance-associated macrophage protein gene; OSP, outer surface protein; p.i., postinfection; WT, wild type. Back

Received for publication June 3, 2003. Accepted for publication August 27, 2003.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Janeway, C. A., Jr, R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197.[Medline]
  2. Akira, S., K. Takeda, T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immun. 2:675.[Medline]
  3. Aderem, A., R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406:782.[Medline]
  4. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11:443.[Medline]
  5. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, et al 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732.[Abstract/Free Full Text]
  6. Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419.[Abstract/Free Full Text]
  7. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J. Immunol. 162:3749.[Abstract/Free Full Text]
  8. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science 282:2085.[Abstract/Free Full Text]
  9. Dunne, A., and L. A. O’Neill. 2003. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 171:rel3.
  10. Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, C. A. Janeway, Jr. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2:253.[Medline]
  11. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143.[Medline]
  12. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115.[Medline]
  13. Schnare, M., G. M. Barton, A. C. Holt, K. Takeda, S. Akira, R. Medzhitov. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immun. 2:947.[Medline]
  14. Takeuchi, O., K. Hoshino, S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392.[Abstract/Free Full Text]
  15. Seki, E., H. Tsutsui, N. M. Tsuji, N. Hayashi, K. Adachi, H. Nakano, S. Futatsugi-Yumikura, O. Takeuchi, K. Hoshino, S. Akira, et al 2002. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J. Immunol. 169:3863.[Abstract/Free Full Text]
  16. Edelson, B. T., E. R. Unanue. 2002. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J. Immunol. 169:3869.[Abstract/Free Full Text]
  17. Scanga, C. A., J. Aliberti, D. Jankovic, F. Tilloy, S. Bennouna, E. Y. Denkers, R. Medzhitov, A. Sher. 2002. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168:5997.[Abstract/Free Full Text]
  18. Horsburgh, C. R., Jr. 1991. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N. Engl. J. Med. 324:1332.[Medline]
  19. Kaplan, J. E., D. Hanson, M. S. Dworkin, T. Frederick, J. Bertolli, M. L. Lindegren, S. Holmberg, J. L. Jones. 2000. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 30:(Suppl. 1):S5.
  20. Palella, F. J., Jr, K. M. Delaney, A. C. Moorman, M. O. Loveless, J. Fuhrer, G. A. Satten, D. J. Aschman, S. D. Holmberg. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators. N. Engl. J. Med. 338:853.[Abstract/Free Full Text]
  21. Flynn, J. L., J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93.[Medline]
  22. Cooper, A. M., L. B. Adams, D. K. Dalton, R. Appelberg, S. Ehlers. 2002. IFN-{gamma} and NO in mycobacterial disease: new jobs for old hands. Trends Microbiol. 10:221.[Medline]
  23. Doherty, T. M., A. Sher. 1997. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. J. Immunol. 158:4822.[Abstract]
  24. Silva, R. A., M. Florido, R. Appelberg. 2001. Interleukin-12 primes CD4+ T cells for interferon-{gamma} production and protective immunity during Mycobacterium avium infection. Immunology 103:368.[Medline]
  25. Abel, B., N. Thieblemont, V. J. Quesniaux, N. Brown, J. Mpagi, K. Miyake, F. Bihl, B. Ryffel. 2002. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 169:3155.[Abstract/Free Full Text]
  26. Reiling, N., C. Holscher, A. Fehrenbach, S. Kroger, C. J. Kirschning, S. Goyert, S. Ehlers. 2002. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 169:3480.[Abstract/Free Full Text]
  27. Hochholzer, P., G. B. Lipford, H. Wagner, K. Pfeffer, K. Heeg. 2000. Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice. Infect. Immun. 68:3502.[Abstract/Free Full Text]
  28. Appelberg, R., A. M. Sarmento. 1990. The role of macrophage activation and of BCG-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice. Clin. Exp. Immunol. 80:324.[Medline]
  29. Castro, A. G., P. Minoprio, R. Appelberg. 1995. The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice. Immunology 85:556.[Medline]
  30. Medina, E., B. J. Rogerson, R. J. North. 1996. The Nramp1 antimicrobial resistance gene segregates independently of resistance to virulent Mycobacterium tuberculosis. Immunology 88:479.[Medline]
  31. Feng, C. G., M. C. Kullberg, D. Jankovic, A. W. Cheever, P. Caspar, R. L. Coffman, A. Sher. 2002. Transgenic mice expressing human interleukin-10 in the antigen-presenting cell compartment show increased susceptibility to infection with Mycobacterium avium associated with decreased macrophage effector function and apoptosis. Infect. Immun. 70:6672.[Abstract/Free Full Text]
  32. Bertolino, P., W. R. Heath, C. L. Hardy, G. Morahan, J. F. Miller. 1995. Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur. J. Immunol. 25:1932.[Medline]
  33. Gregory, S. H., E. J. Wing. 2002. Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J. Leukocyte Biol. 72:239.[Abstract/Free Full Text]
  34. Gregory, S. H., A. J. Sagnimeni, E. J. Wing. 1996. Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J. Immunol. 157:2514.[Abstract]
  35. Means, T. K., S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, M. J. Fenton. 1999. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163:3920.[Abstract/Free Full Text]
  36. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383.[Medline]
  37. Means, T. K., B. W. Jones, A. B. Schromm, B. A. Shurtleff, J. A. Smith, J. Keane, D. T. Golenbock, S. N. Vogel, M. J. Fenton. 2001. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J. Immunol. 166:4074.[Abstract/Free Full Text]
  38. Heldwein, K. A., M. J. Fenton. 2002. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect. 4:937.[Medline]
  39. Ehlers, S., J. Benini, S. Kutsch, R. Endres, E. T. Rietschel, K. Pfeffer. 1999. Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect. Immun. 67:3571.[Abstract/Free Full Text]
  40. Appelberg, R., A. G. Castro, S. Gomes, J. Pedrosa, M. T. Silva. 1995. Susceptibility of beige mice to Mycobacterium avium: role of neutrophils. Infect. Immun. 63:3381.[Abstract]
  41. Petrofsky, M., L. E. Bermudez. 1999. Neutrophils from Mycobacterium avium-infected mice produce TNF-{alpha}, IL-12, and IL-1{beta} and have a putative role in early host response. Clin. Immunol. 91:354.[Medline]
  42. Pedrosa, J., B. M. Saunders, R. Appelberg, I. M. Orme, M. T. Silva, A. M. Cooper. 2000. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect. Immun. 68:577.[Abstract/Free Full Text]
  43. Fulton, S. A., S. M. Reba, T. D. Martin, W. H. Boom. 2002. Neutrophil-mediated mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 mice. Infect. Immun. 70:5322.[Abstract/Free Full Text]
  44. Neufert, C., R. K. Pai, E. H. Noss, M. Berger, W. H. Boom, C. V. Harding. 2001. Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation. J. Immunol. 167:1542.[Abstract/Free Full Text]
  45. Vabulas, R. M., P. Ahmad-Nejad, S. Ghose, C. J. Kirschning, R. D. Issels, H. Wagner. 2002. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277:15107.[Abstract/Free Full Text]
  46. Ohashi, K., V. Burkart, S. Flohe, H. Kolb. 2000. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J. Immunol. 164:558.[Abstract/Free Full Text]
  47. Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens, K. Miyake, M. Freudenberg, C. Galanos, J. C. Simon. 2002. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195:99.[Abstract/Free Full Text]
  48. Smiley, S. T., J. A. King, W. W. Hancock. 2001. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167:2887.[Abstract/Free Full Text]
  49. Tokunaga, T., O. Yano, E. Kuramoto, Y. Kimura, T. Yamamoto, T. Kataoka, S. Yamamoto. 1992. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol. Immunol. 36:55.[Medline]
  50. Sonehara, K., H. Saito, E. Kuramoto, S. Yamamoto, T. Yamamoto, T. Tokunaga. 1996. Hexamer palindromic oligonucleotides with 5'-CG-3' motif(s) induce production of interferon. J. Interferon Cytokine Res. 16:799.[Medline]
  51. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740.[Medline]

Related articles in The JI:

IN THIS ISSUE

The JI 2003 171: 4471-4472. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J.-Q. Gu, S. Ikuyama, P. Wei, B. Fan, J.-i. Oyama, T. Inoguchi, and J. Nishimura
Pycnogenol, an extract from French maritime pine, suppresses Toll-like receptor 4-mediated expression of adipose differentiation-related protein in macrophages
Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1390 - E1400.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-S. Shi and J. H. Kehrl
MyD88 and Trif Target Beclin 1 to Trigger Autophagy in Macrophages
J. Biol. Chem., November 28, 2008; 283(48): 33175 - 33182.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Sweet, W. Zhang, H. Torres-Fewell, A. Serianni, W. Boggess, and J. Schorey
Mycobacterium avium Glycopeptidolipids Require Specific Acetylation and Methylation Patterns for Signaling through Toll-like Receptor 2
J. Biol. Chem., November 28, 2008; 283(48): 33221 - 33231.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
E. P. Sampaio, H. Z. Elloumi, A. Zelazny, L. Ding, M. L. Paulson, A. Sher, A. L. Bafica, Y. R. Shea, and S. M. Holland
Mycobacterium abscessus and M. avium Trigger Toll-Like Receptor 2 and Distinct Cytokine Response in Human Cells
Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 431 - 439.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. De Pascalis, B. C. Taylor, and K. L. Elkins
Diverse Myeloid and Lymphoid Cell Subpopulations Produce Gamma Interferon during Early Innate Immune Responses to Francisella tularensis Live Vaccine Strain
Infect. Immun., September 1, 2008; 76(9): 4311 - 4321.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
O. S. Shin, R. R. Isberg, S. Akira, S. Uematsu, A. K. Behera, and L. T. Hu
Distinct Roles for MyD88 and Toll-Like Receptors 2, 5, and 9 in Phagocytosis of Borrelia burgdorferi and Cytokine Induction
Infect. Immun., June 1, 2008; 76(6): 2341 - 2351.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. J. Weiss, C. D. Souza, O. A. Evanson, M. Sanders, and M. Rutherford
Bovine monocyte TLR2 receptors differentially regulate the intracellular fate of Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium
J. Leukoc. Biol., January 1, 2008; 83(1): 48 - 55.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Stenzel, S. Soltek, M. Sanchez-Ruiz, S. Akira, H. Miletic, D. Schluter, and M. Deckert
Both TLR2 and TLR4 Are Required for the Effective Immune Response in Staphylococcus aureus-Induced Experimental Murine Brain Abscess
Am. J. Pathol., January 1, 2008; 172(1): 132 - 145.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Macedo, G. Pinhal-Enfield, V. Alshits, G. Elson, B. N. Cronstein, and S. J. Leibovich
Wound Healing Is Impaired in MyD88-Deficient Mice: A Role for MyD88 in the Regulation of Wound Healing by Adenosine A2A Receptors
Am. J. Pathol., December 1, 2007; 171(6): 1774 - 1788.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
Y. J. Ryu, E. J. Kim, S-H. Lee, S. Y. Kim, G. Y. Suh, M. P. Chung, H. Kim, O. J. Kwon, and W-J. Koh
Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease
Eur. Respir. J., October 1, 2007; 30(4): 736 - 742.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C.-L. Ku, H. von Bernuth, C. Picard, S.-Y. Zhang, H.-H. Chang, K. Yang, M. Chrabieh, A. C. Issekutz, C. K. Cunningham, J. Gallin, et al.
Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity
J. Exp. Med., October 1, 2007; 204(10): 2407 - 2422.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Bhan, N. W. Lukacs, J. J. Osterholzer, M. W. Newstead, X. Zeng, T. A. Moore, T. R. McMillan, A. M. Krieg, S. Akira, and T. J. Standiford
TLR9 Is Required for Protective Innate Immunity in Gram-Negative Bacterial Pneumonia: Role of Dendritic Cells
J. Immunol., September 15, 2007; 179(6): 3937 - 3946.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Fremond, D. Togbe, E. Doz, S. Rose, V. Vasseur, I. Maillet, M. Jacobs, B. Ryffel, and V. F. J. Quesniaux
IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection
J. Immunol., July 15, 2007; 179(2): 1178 - 1189.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. O. Watson, V. Novik, D. Hofreuter, M. Lara-Tejero, and J. E. Galan
A MyD88-Deficient Mouse Model Reveals a Role for Nramp1 in Campylobacter jejuni Infection
Infect. Immun., April 1, 2007; 75(4): 1994 - 2003.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. D. Bolz, R. S. Sundsbak, Y. Ma, S. Akira, J. H. Weis, T. G. Schwan, and J. J. Weis
Dual Role of MyD88 in Rapid Clearance of Relapsing Fever Borrelia spp.
Infect. Immun., December 1, 2006; 74(12): 6750 - 6760.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Yadav and J. S. Schorey
The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria
Blood, November 1, 2006; 108(9): 3168 - 3175.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. H. Mogensen, S. R. Paludan, M. Kilian, and L. Ostergaard
Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns
J. Leukoc. Biol., August 1, 2006; 80(2): 267 - 277.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. Sweet and J. S. Schorey
Glycopeptidolipids from Mycobacterium avium promote macrophage activation in a TLR2- and MyD88-dependent manner
J. Leukoc. Biol., August 1, 2006; 80(2): 415 - 423.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
Y. J. Ryu, E. J. Kim, W.-J. Koh, H. Kim, O J. Kwon, and J. H. Chang
Toll-Like Receptor 2 Polymorphisms and Nontuberculous Mycobacterial Lung Diseases.
Clin. Vaccine Immunol., July 1, 2006; 13(7): 818 - 819.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. D. Pecora, A. J. Gehring, D. H. Canaday, W. H. Boom, and C. V. Harding
Mycobacterium tuberculosis LprA Is a Lipoprotein Agonist of TLR2 That Regulates Innate Immunity and APC Function
J. Immunol., July 1, 2006; 177(1): 422 - 429.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. A. Archer and C. R. Roy
MyD88-Dependent Responses Involving Toll-Like Receptor 2 Are Important for Protection and Clearance of Legionella pneumophila in a Mouse Model of Legionnaires' Disease.
Infect. Immun., June 1, 2006; 74(6): 3325 - 3333.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. M. van der Sar, O. W. Stockhammer, C. van der Laan, H. P. Spaink, W. Bitter, and A. H. Meijer
MyD88 Innate Immune Function in a Zebrafish Embryo Infection Model
Infect. Immun., April 1, 2006; 74(4): 2436 - 2441.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. K. Behera, E. Hildebrand, R. T. Bronson, G. Perides, S. Uematsu, S. Akira, and L. T. Hu
MyD88 Deficiency Results in Tissue-Specific Changes in Cytokine Induction and Inflammation in Interleukin-18-Independent Mice Infected with Borrelia burgdorferi
Infect. Immun., March 1, 2006; 74(3): 1462 - 1470.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
Y.-T.A. Teng
Protective and Destructive Immunity in the Periodontium: Part 1--Innate and Humoral Immunity and the Periodontium
Journal of Dental Research, March 1, 2006; 85(3): 198 - 208.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. Bafica, C. A. Scanga, C. G. Feng, C. Leifer, A. Cheever, and A. Sher
TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis
J. Exp. Med., December 19, 2005; 202(12): 1715 - 1724.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Fuse, G. Chan, Y. Liu, P. Gudgeon, M. Husain, M. Chen, W.-C. Yeh, S. Akira, and P. P. Liu
Myeloid Differentiation Factor-88 Plays a Crucial Role in the Pathogenesis of Coxsackievirus B3-Induced Myocarditis and Influences Type I Interferon Production
Circulation, October 11, 2005; 112(15): 2276 - 2285.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Matsumoto, M. Matsumoto, K. Umemori, Y. Ozeki, M. Furugen, T. Tatsuo, Y. Hirayama, S. Yamamoto, T. Yamada, and K. Kobayashi
DNA Augments Antigenicity of Mycobacterial DNA-Binding Protein 1 and Confers Protection against Mycobacterium tuberculosis Infection in Mice
J. Immunol., July 1, 2005; 175(1): 441 - 449.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Blumenthal, J. Lauber, R. Hoffmann, M. Ernst, C. Keller, J. Buer, S. Ehlers, and N. Reiling
Common and Unique Gene Expression Signatures of Human Macrophages in Response to Four Strains of Mycobacterium avium That Differ in Their Growth and Persistence Characteristics
Infect. Immun., June 1, 2005; 73(6): 3330 - 3341.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Isogawa, M. D. Robek, Y. Furuichi, and F. V. Chisari
Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In Vivo
J. Virol., June 1, 2005; 79(11): 7269 - 7272.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. M. Zughaier, S. M. Zimmer, A. Datta, R. W. Carlson, and D. S. Stephens
Differential Induction of the Toll-Like Receptor 4-MyD88-Dependent and -Independent Signaling Pathways by Endotoxins
Infect. Immun., May 1, 2005; 73(5): 2940 - 2950.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. W. Wieland, S. Knapp, S. Florquin, A. F. de Vos, K. Takeda, S. Akira, D. T. Golenbock, A. Verbon, and T. van der Poll
Non-Mannose-capped Lipoarabinomannan Induces Lung Inflammation via Toll-like Receptor 2
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1367 - 1374.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. Janssen, A. van Wengen, M. A. Hoeve, M. ten Dam, M. van der Burg, J. van Dongen, E. van de Vosse, M. van Tol, R. Bredius, T. H. Ottenhoff, et al.
The Same I{kappa}B{alpha} Mutation in Two Related Individuals Leads to Completely Different Clinical Syndromes
J. Exp. Med., September 7, 2004; 200(5): 559 - 568.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. D. Bolz, R. S. Sundsbak, Y. Ma, S. Akira, C. J. Kirschning, J. F. Zachary, J. H. Weis, and J. J. Weis
MyD88 Plays a Unique Role in Host Defense but Not Arthritis Development in Lyme Disease
J. Immunol., August 1, 2004; 173(3): 2003 - 2010.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Bafica, C. A. Scanga, M. Schito, D. Chaussabel, and A. Sher
Influence of Coinfecting Pathogens on HIV Expression: Evidence for a Role of Toll-Like Receptors
J. Immunol., June 15, 2004; 172(12): 7229 - 7234.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. G. Netea, C. van der Graaf, J. W. M. Van der Meer, and B. J. Kullberg
Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system
J. Leukoc. Biol., May 1, 2004; 75(5): 749 - 755.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. A. Scanga, A. Bafica, C. G. Feng, A. W. Cheever, S. Hieny, and A. Sher
MyD88-Deficient Mice Display a Profound Loss in Resistance to Mycobacterium tuberculosis Associated with Partially Impaired Th1 Cytokine and Nitric Oxide Synthase 2 Expression
Infect. Immun., April 1, 2004; 72(4): 2400 - 2404.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feng, C. G.
Right arrow Articles by Sher, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, C. G.
Right arrow Articles by Sher, A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Tuberculosis


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS